MDT perspectives on biologic treatment selection in severe type 2 asthma

touchMDT for touchIMMUNOLOGY

Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.

The multidisciplinary team 

• Allergist: Professor Ioana Agache, Romania
• Primary care physician: Professor Barbara Yawn, USA
• Pulmonologist: Professor Alberto Papi, Italy

This touchPODCAST is for HCPs only.

This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

For further information visit our website: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//